Earnings
NeoGenomics Says One Dropped Customer Skewed Volume And Price Growth, Lifts 2026 Revenue Outlook
The cancer-testing company's 11% average unit price gain and slower volume trace to one unprofitable account, its CFO said.
NEO
NeoGenomics (NEO) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
NeoGenomics CEO Zook Says Succession Was Planned, And He Was Handed A Budget He Couldn't Shape
Outgoing CEO Tony Zook says Warren Stone will own the coming budget, and the company plans an investor day in the first half of 2027.
SEC Filings
NeoGenomics Receivables Jump $54 Million, Swallowing Its Operating Cash Flow
A billing-platform switch left invoices unsent, and operating cash flow shrank to $2.9 million for the first nine months.
Earnings
NeoGenomics Lifts 2026 Outlook As Third-Quarter Net Loss Shrinks To $8 Million From $27 Million
The cancer testing lab also named President and COO Warren Stone as its next CEO, effective January 4, 2027.
SEC Filings
NeoGenomics Picks COO Warren Stone To Succeed CEO Tony Zook On January 4, 2027
An 8-K sets Stone's pay at $850,000 base salary, and the company says it expects to raise its full-year revenue guidance.